Overall, progression-free survival worse for oligometastatic NSCLC patients with versus without detectable ctDNA before radiotherapy
PLCOm2012 models have higher sensitivity than USPSTF criteria, with no difference by Indigenous classification
Model relies only on age, smoking duration, and pack-years
Early menarche, early menopause, shortened reproductive life span linked to increased risk, especially for NSCLC
Intensity-modulated radiation therapy spares more normal tissue than 3D-conformal radiotherapy
Removal of race correction was tied to a significant reduction in the estimation of lung function for African Americans
Meta-analysis only shows a 110-day survival benefit for colorectal cancer screening with sigmoidoscopy
Single-site cancer screening could save an additional 3.2 to 5.1 million life-years with perfect adherence
First-line atezolizumab monotherapy is associated with improved overall survival compared with single-agent chemotherapy
Median time to treatment was 39 days for ACCELERATE cohort versus 62 days for reference cohort using standard tissue genotyping